Abbott has commenced the first subject procedures with its transcatheter aortic valve implantation (TAVI) system to treat ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not ...

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart ...

A toddler from Bonhill who underwent open-heart surgery at just four weeks old has been named a Young Heart Hero for his ...

Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime XL aortic valve system.

Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement ...

LONDON, ENGLAND—Clinical and echocardiographic outcomes with the latest-generation balloon-expandable Sapien 3 Ultra Resilia ...

Echo IQ executive chair Andrew Grover is generally cheerful and optimistic, but wasn't in the weeks leading up to the US ...